- Home
- SGU vs ETON Comparison
SGU vs ETON Comparison
Compare SGU & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGU
- ETON
- Stock Information
- Founded
- SGU 1995
- ETON 2017
- Country
- SGU United States
- ETON United States
- Employees
- SGU N/A
- ETON N/A
- Industry
- SGU Other Specialty Stores
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- SGU Consumer Discretionary
- ETON Health Care
- Exchange
- SGU Nasdaq
- ETON Nasdaq
- Market Cap
- SGU 388.5M
- ETON 388.3M
- IPO Year
- SGU 1995
- ETON 2018
- Fundamental
- Price
- SGU $11.59
- ETON $17.78
- Analyst Decision
- SGU
- ETON Strong Buy
- Analyst Count
- SGU 0
- ETON 3
- Target Price
- SGU N/A
- ETON $29.67
- AVG Volume (30 Days)
- SGU 39.2K
- ETON 240.4K
- Earning Date
- SGU 08-06-2025
- ETON 11-11-2025
- Dividend Yield
- SGU 6.34%
- ETON N/A
- EPS Growth
- SGU 33.71
- ETON N/A
- EPS
- SGU 1.66
- ETON N/A
- Revenue
- SGU $1,777,057,000.00
- ETON $58,181,000.00
- Revenue This Year
- SGU N/A
- ETON $105.25
- Revenue Next Year
- SGU N/A
- ETON $40.84
- P/E Ratio
- SGU $6.97
- ETON N/A
- Revenue Growth
- SGU N/A
- ETON 85.40
- 52 Week Low
- SGU $10.84
- ETON $4.73
- 52 Week High
- SGU $13.75
- ETON $21.48
- Technical
- Relative Strength Index (RSI)
- SGU 45.54
- ETON 60.35
- Support Level
- SGU $11.51
- ETON $17.22
- Resistance Level
- SGU $11.72
- ETON $18.06
- Average True Range (ATR)
- SGU 0.20
- ETON 0.62
- MACD
- SGU -0.00
- ETON -0.05
- Stochastic Oscillator
- SGU 23.08
- ETON 60.80
About SGU Star Group L.P.
Star Group LP is a company engaged in providing home heating products and services to residential and commercial customers. The company offers heating oil and air conditioning equipment, as well as home security and plumbing services. The company also sells diesel fuel, gasoline, and home heating oil. Geographically, the company operates in U.S.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.